|
|
||||||||
|
|
|||||||||
|
|
Oncology-Basic Science: Therapy, Metrics & InterventionTherapy, Metrics & Intervention Posters |
1 China Medical University, Taipei, Taiwan; 2 MAGIC/NRPGM, National Yang-Ming University, Taipei, Taiwan; 3 NPCC, Taipei VGH, Taipei, Taiwan
1413
Objectives: The low temporal resolution and cytototoxicity of reporter protein of HSV1-tk/GFP (TKGFP) limited its use in the translational medicine. This study aims to create a new TKGFP fusion gene with low cytototoxicity and high temporal resolution for real-time monitoring the temporal dynamics and spatial heterogeneity of gene expression events.
Methods: This reporter was developed by adding a nuclear export signal (NES) in the N-terminal end of TKGFP and fusing the degradation domain of mouse ornithine decaroxylase (MODC) to the C-terminal end. This modified TKGFP (NESTKGFP:dMODC), was unstable in the presence of cycloheximide and had a short half-life of protein and enzyme activity determined by western blot analysis, HSV1-TK enzyme activity assay and FACS. The proteasome inhibition assay also confirmed that the rapid turnover of the modified HSV1-TK was processed in a 26S proteasome-dependent manner. The suitability of NESTKGFP:dMODC as a transcription reporter was tested by linking it to a promoter consisting of 8 copies of hypoxia response elements (HRE) whose activity depends on hypoxia -inducible factor-1 (HIF-1).
Results: Cell proliferation assay demonstrated no growth inhibition was observed in NESTKGFP:dMODC-transfected cells. In the hypoxia treatment, both of TK enzyme activity and fluorescent intensity in native TKGFP or NESTKGFP:dMODC correlated with the mRNA expression levels of VEGF and the magnitude of hypoxia stimulations. Re-oxygenation rapidly decreased TK enzyme activity and fluorescence intensity for NESTKGFP:dMODC reporter in vitro and in vivo.
Conclusions: The novel NESTKGFP:dMODC reporter is suitable for the real-time imaging of temporal dynamics and spatial heterogeneity of HIF-1 signal transduction activity in vitro and in vivo.
| ||||||||||||||||||||||||||||||||||||||